Shane Ward Cidara Therapeutics, Inc. (CDTX) insider trading activity

CDTX Quotes by TradingView

Shane Ward is COO & CLO of Cidara Therapeutics, Inc.. Currently has a direct ownership of 318,770 shares of CDTX, which is worth approximately $3.57 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 120,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 319K
50.9% 3M change
50.9% 12M change
Total Value Held $3.57 Million

Shane Ward Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
-
120,000 Added 27.35%
318,770 Common Stock
Mar 11 2024
SELL
Open market or private sale
$13,716 $0.67 p/Share
20,473 Reduced 9.34%
198,770 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
126,667 Added 37.49%
211,243 Common Stock
Mar 13 2023
SELL
Open market or private sale
$6,623 $1.53 p/Share
4,329 Reduced 4.87%
84,576 Common Stock
Mar 31 2022
SELL
Payment of exercise price or tax liability
$19,191 $0.83 p/Share
23,122 Reduced 22.23%
80,905 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
104,027 Added 50.0%
104,027 Common Stock
SW

Shane Ward

COO & CLO
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CDTX